Amarin Corp Plc (AMRN)

[wikthor]

Perfectly valid reasoning.
I'm going to believe that in countries with public health system and negotiating prices (not like in the USA based on discount cards), as soon as things go well, you can ask for $3B and the usual multiplier is more, like x5.

Another thing is that it generates hype for other research or lines with the same molecule (imagine, same product, without sales changes and new patents) or the combo with the statin:
Market expected $17.34 Bn by 2027

I still think that Pfizer in Canada is NOT a coincidence. She can multiply x2 or x3 those sales and product lines.

I keep saying and I have put it more times, MY personal opinion and I will stay until the end.